Fate Therapeutics, Inc. (FATE) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 179.53M | 208.7M | 221.25M | 230.4M | 248.22M | 291.91M | 310.29M | 319.39M | 394.38M | 331.54M | 364.17M | 392.18M |
| Cash & Short-Term Investments | 174.82M | 203.66M | 215.42M | 222.83M | 240.43M | 279.07M | 296.92M | 304.88M | 383.54M | 315.18M | 349.73M | 377.94M |
| Cash Only | 39.57M | 46.63M | 40.62M | 41.25M | 44.92M | 36.06M | 37.91M | 36.92M | 121.32M | 41.87M | 33.33M | 46.8M |
| Short-Term Investments | 135.25M | 157.03M | 174.8M | 181.58M | 195.5M | 243.01M | 259.01M | 267.96M | 262.22M | 273.31M | 316.4M | 331.13M |
| Accounts Receivable | 704K | 916K | 682K | 1.4M | 2.41M | 3.54M | 4.13M | 1.05M | 858K | 1.83M | 1.54M | 2.83M |
| Days Sales Outstanding | 56.12 | 53.69 | 54.88 | 90.69 | 164.23 | 189.59 | 77.44 | 12.81 | 63.44 | 92.33 | 103.43 | 796.52 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4M | 4.13M | 5.15M | 6.17M | 5.39M | 9.3M | 1.9M | 1.7M | 9.97M | 900K | 12.9M | 1.1M |
| Total Non-Current Assets | 105.39M | 110.23M | 122.42M | 141.24M | 150.45M | 148.78M | 184.68M | 209.43M | 175.52M | 174.68M | 179.61M | 192.57M |
| Property, Plant & Equipment | 95.34M | 98.53M | 101.89M | 104.91M | 107.94M | 110.89M | 140.83M | 147.08M | 152.74M | 158.51M | 164.43M | 170.07M |
| Fixed Asset Turnover | 0.01x | 0.01x | 0.02x | 0.02x | 0.01x | 0.01x | 0.02x | 0.05x | 0.01x | 0.01x | 0.01x | 0.01x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 1.47M | 10.3M | 26.1M | 32.29M | 27.66M | 33.61M | 47.16M | 7.59M | 980K | 15.18M | 7.29M |
| Other Non-Current Assets | 10.05M | 10.23M | 10.23M | 10.23M | 10.23M | 10.24M | 10.24M | 15.19M | 15.19M | 15.19M | 9K | 15.21M |
| Total Assets | 284.92M | 318.94M | 343.67M | 371.63M | 398.67M | 440.69M | 494.97M | 528.82M | 569.89M | 506.22M | 543.79M | 584.76M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -28.53% | -27.63% | -30.57% | -29.72% | -30.04% | -12.94% | -8.98% | -9.57% | -9.59% | -28.25% | -27.43% | -27.54% |
| Total Current Liabilities | 30.69M | 36.07M | 28.11M | 28.67M | 28.16M | 38.52M | 37.42M | 34.79M | 45.37M | 39.09M | 41.33M | 44.69M |
| Accounts Payable | 3.28M | 2.66M | 3.5M | 4.04M | 4.19M | 9.37M | 6.35M | 5.5M | 6.76M | 4.72M | 5.71M | 7.51M |
| Days Payables Outstanding | 91.5 | - | - | - | - | - | - | 118.16 | 108.38 | 98.17 | 128.22 | 19.32 |
| Short-Term Debt | 4.74M | 4.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.98M | 0 |
| Deferred Revenue (Current) | 582K | 381K | 5K | 0 | 212K | 393K | 600K | 0 | 159K | 0 | 1.11M | 0 |
| Other Current Liabilities | 22.09M | 28.47M | 2.28M | 795K | 0 | 11.64M | 0 | 15.39M | 0 | 685K | 19.48M | 1.93M |
| Current Ratio | 5.85x | 5.79x | 7.87x | 8.04x | 8.81x | 7.58x | 8.29x | 9.18x | 8.69x | 8.48x | 8.81x | 8.78x |
| Quick Ratio | 5.85x | 5.79x | 7.87x | 8.04x | 8.81x | 7.58x | 8.29x | 9.18x | 8.69x | 8.48x | 8.81x | 8.78x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 74.52M | 75.68M | 81.49M | 81.59M | 82.1M | 83.45M | 95.22M | 97.04M | 98.41M | 98.71M | 99.68M | 102.31M |
| Long-Term Debt | 72.05M | 73.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 74.49M | 75.67M | 76.78M | 77.85M | 92.08M | 93.92M | 95.67M | 97.36M | 98.98M | 100.56M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.48M | 2.4M | 7M | 5.92M | 5.32M | 5.6M | 3.14M | 3.12M | 2.74M | 1.35M | 701K | 1.75M |
| Total Liabilities | 105.21M | 111.75M | 109.61M | 110.27M | 110.26M | 121.97M | 132.64M | 131.84M | 143.78M | 137.8M | 141.01M | 147M |
| Total Debt | 76.78M | 77.85M | 79.25M | 81.33M | 83.33M | 85.27M | 98.98M | 100.56M | 102.07M | 103.54M | 104.95M | 106.35M |
| Net Debt | 37.22M | 31.22M | 38.62M | 40.08M | 38.41M | 49.21M | 61.07M | 63.65M | -19.25M | 61.67M | 71.62M | 59.55M |
| Debt / Equity | 0.43x | 0.38x | 0.34x | 0.31x | 0.29x | 0.27x | 0.27x | 0.25x | 0.24x | 0.28x | 0.26x | 0.24x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 179.71M | 207.18M | 234.07M | 261.36M | 288.41M | 318.73M | 362.33M | 396.98M | 426.12M | 368.42M | 402.78M | 437.75M |
| Equity Growth % | -37.69% | -35% | -35.4% | -34.16% | -32.32% | -13.49% | -10.04% | -9.31% | -10.76% | -23.87% | -22.24% | -24.59% |
| Book Value per Share | 1.50 | 1.74 | 1.97 | 2.21 | 2.44 | 2.71 | 3.08 | 3.38 | 4.21 | 3.74 | 4.09 | 4.45 |
| Total Shareholders' Equity | 179.71M | 207.18M | 234.07M | 261.36M | 288.41M | 318.73M | 362.33M | 396.98M | 426.12M | 368.42M | 402.78M | 437.75M |
| Common Stock | 116K | 115K | 115K | 115K | 115K | 114K | 114K | 114K | 114K | 99K | 99K | 99K |
| Retained Earnings | -1.57B | -1.53B | -1.5B | -1.47B | -1.44B | -1.4B | -1.35B | -1.3B | -1.26B | -1.21B | -1.17B | -1.12B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -77K | 116K | 153K | 62K | 191K | 268K | 835K | -422K | -194K | 15K | -499K | -587K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |